Nobuyuki Toshikuni
Moriguchi, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Does Burnt-Out MASLD Mark Loss of Hepatic Lipid-Buffering Capacity?
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: August 12, 2026
Can one dissemination time be assigned to polyclonal hepatocellular carcinoma recurrence?
Journal: Gut
Published: July 25, 2026
Internal Inconsistencies in the Training-Cohort Performance Table for the ELM Score.
Journal: Journal of hepatology
Published: July 16, 2026
Letter: Sparse Mortality Events and the Apparent OS Benefit of TDF After HCC Resection.
Journal: Alimentary pharmacology & therapeutics
Published: July 13, 2026
Comment on "Efficacy and Safety of Hypofractionated Radiation Therapy Combined With Immunotherapy for Hepatocellular Carcinoma With Vp4 Portal Vein Tumor Thrombosis".
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: May 28, 2026
Endotype Clustering Contextualizes the Link Between Hepatic Steatosis and High-Risk Coronary Plaque.
Endotype Clustering Contextualizes the Link Between Hepatic Steatosis and High-Risk Coronary Plaque.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: May 22, 2026
Letter: Reassessing Liver Biopsy Deferral in Antinuclear Antibody-Positive Patients: The Clinical Necessity of Objective Fibrosis Staging.
Journal: Alimentary pharmacology & therapeutics
Published: April 25, 2026
Rethinking sustained recompensation in MASLD cirrhosis: The value of pharmacological maintenance.
Journal: Hepatology communications
Published: March 24, 2026
Sonazoid-enhanced ultrasound images of multiacinar cirrhotic nodules showing a "donut-like" hyperintense appearance on Gd-EOB-MRI: a case report.
Journal: Journal of medical ultrasonics (2001)
Published: June 23, 2023
Recombinant thrombomodulin prevented hepatic ischemia-reperfusion injury by inhibiting high-mobility group box 1 in rats.
Journal: European journal of pharmacology
Published: May 17, 2019
The combination of fatty liver and increased gamma-glutamyl transpeptidase levels as a risk factor for atherosclerotic plaque development in apparently healthy people
Journal: Turkish journal of medical sciences
Published: January 22, 2019
Last Updated: 09/26/2026